Parikh R - Search Results

1

Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors.

Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Saif MW, et al. Among authors: parikh r. J Gastrointest Oncol. 2019 Aug;10(4):674-687. doi: 10.21037/jgo.2019.03.11. J Gastrointest Oncol. 2019. PMID: 31392048 Free PMC article.

2

Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims.

Buck PO, Meyers JL, Gordon LD, Parikh R, Kurosky SK, Davis KL. Buck PO, et al. Among authors: parikh r. Epidemiol Infect. 2017 Jul;145(10):2109-2121. doi: 10.1017/S0950268817000887. Epub 2017 May 2. Epidemiol Infect. 2017. PMID: 28462763 Free PMC article.

3

Treatment Patterns and Health Outcomes in Platinum-Refractory or Platinum-Resistant Ovarian Cancer: A Retrospective Medical Record Review.

Parikh R, Kurosky SK, Udall M, Chang J, Cappelleri JC, Doherty JP, Kaye JA. Parikh R, et al. Int J Gynecol Cancer. 2018 May;28(4):738-748. doi: 10.1097/IGC.0000000000001222. Int J Gynecol Cancer. 2018. PMID: 29538247

4

Treatment patterns and survival among older adults in the United States with advanced soft-tissue sarcomas.

Parikh RC, Lorenzo M, Hess LM, Candrilli SD, Nicol S, Kaye JA. Parikh RC, et al. Clin Sarcoma Res. 2018 May 3;8:8. doi: 10.1186/s13569-018-0094-x. eCollection 2018. Clin Sarcoma Res. 2018. PMID: 29744029 Free PMC article.

5

Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United States.

Goyal RK, Cuyun Carter G, Nagar SP, Nash Smyth E, Price GL, Parikh RC, Huang YJ, Li L, Davis KL, Kaye JA. Goyal RK, et al. Expert Rev Pharmacoecon Outcomes Res. 2021 Aug;21(4):699-710. doi: 10.1080/14737167.2020.1804871. Epub 2020 Sep 14. Expert Rev Pharmacoecon Outcomes Res. 2021. PMID: 32755262

6

Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancer.

Parikh R, Hess LM, Esterberg E, Bhandari NR, Kaye JA. Parikh R, et al. Thyroid Res. 2022 Feb 12;15(1):2. doi: 10.1186/s13044-021-00119-9. Thyroid Res. 2022. PMID: 35151352 Free PMC article.

7

Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the USA.

Bhandari NR, Hess LM, Parikh RC, Sireci AN, Krein PM, Kaye JA. Bhandari NR, et al. Per Med. 2023 Mar;20(2):131-142. doi: 10.2217/pme-2022-0050. Epub 2023 Feb 7. Per Med. 2023. PMID: 36749615 Free article.

8

Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record review.

Passamonti F, Heidel FH, Parikh RC, Ajmera M, Tang D, Nadal JA, Davis KL, Abraham P. Passamonti F, et al. Future Oncol. 2022 Jun;18(18):2217-2231. doi: 10.2217/fon-2021-1358. Epub 2022 Apr 7. Future Oncol. 2022. PMID: 35388710 Free article.

9

International practice patterns and resource utilization in the treatment of neuroendocrine tumors.

Casciano R, Wang X, Stern L, Parikh R, Chulikavit M, Willet J, Liu Z, Strosberg J, Cadiot G, Riechelmann R. Casciano R, et al. Among authors: parikh r. Pancreas. 2013 Mar;42(2):339-47. doi: 10.1097/MPA.0b013e31826707cc. Pancreas. 2013. PMID: 23357923

10

Treatment patterns and health care resource utilization among Japanese patients with ankylosing spondylitis: A hospital claims database analysis.

Tomita T, Sato M, Esterberg E, Parikh RC, Hagimori K, Nakajo K. Tomita T, et al. Mod Rheumatol. 2021 Mar;31(2):431-441. doi: 10.1080/14397595.2020.1775927. Epub 2020 Jun 19. Mod Rheumatol. 2021. PMID: 32476522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,037 results

Search Page